Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic
- PMID: 32983254
- PMCID: PMC7509820
- DOI: 10.1186/s13027-020-00322-7
Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic
Abstract
The rapid growth of 2019 novel coronavirus (COVID-19) outbreak in Wuhan, China, at the early December 2019. COVID-19 spread all over the word just a few months. The outbreak of COVID-19 infection poses major threat to international health and economy. World Health Organization (WHO) announced that the new coronavirus was an international public health emergency on January 30, 2020. However, with the spread of COVID-19, the routine medical care of lung cancer patients was affected. Because lung cancer patients have low immunity after anti-tumor treatment, they should become the main targets for epidemic prevention. Lung cancer patients are increasingly concerned about the prevention of COVID-19. It is necessary to provide individualized medical treatment and management for lung cancer patients based on patients' conditions and regional epidemic patterns.
Keywords: COVID-19; Lung cancer; Patient management.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsThe authors report no conflicts of interest in this work.
Similar articles
-
Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic.Thorac Cancer. 2020 Jun;11(6):1752-1757. doi: 10.1111/1759-7714.13424. Epub 2020 Apr 14. Thorac Cancer. 2020. PMID: 32291968 Free PMC article.
-
[Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19)].Zhongguo Fei Ai Za Zhi. 2020 Mar 20;23(3):136-141. doi: 10.3779/j.issn.1009-3419.2020.03.02. Epub 2020 Feb 20. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32077441 Free PMC article. Chinese.
-
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27. Oncologist. 2020. PMID: 32243668 Free PMC article. Review.
-
Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China.Biosci Trends. 2020 Mar 16;14(1):3-8. doi: 10.5582/bst.2020.01043. Epub 2020 Feb 17. Biosci Trends. 2020. PMID: 32062645
-
Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China.Acta Virol. 2020;64(2):245-250. doi: 10.4149/av_2020_201. Acta Virol. 2020. PMID: 32551792 Review.
Cited by
-
Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis.Transl Oncol. 2023 Feb;28:101605. doi: 10.1016/j.tranon.2022.101605. Epub 2022 Dec 19. Transl Oncol. 2023. PMID: 36568513 Free PMC article.
-
Cancer du poumon à l’ère du COVID-19: Lung cancer in the COVID-19 era.Rev Malad Respir Actual. 2020 Dec;12(2):2S378-2S382. doi: 10.1016/S1877-1203(20)30155-5. Epub 2020 Dec 5. Rev Malad Respir Actual. 2020. PMID: 33312269 Free PMC article. French.
-
Lung Cancer, Covid-19 Infections and Chemotherapy.In Vivo. 2021 May-Jun;35(3):1877-1880. doi: 10.21873/invivo.12450. In Vivo. 2021. PMID: 33910875 Free PMC article.
-
Risk of COVID-19 infection in patients with NSCLC receiving EGFR-TKI targeted therapy during the first wave in China.J Int Med Res. 2024 Oct;52(10):3000605241281907. doi: 10.1177/03000605241281907. J Int Med Res. 2024. PMID: 39387199 Free PMC article.
-
In silico prediction of COVID-19 cytokine storm in lung cancer types.Biochem Biophys Rep. 2022 Dec;32:101350. doi: 10.1016/j.bbrep.2022.101350. Epub 2022 Sep 22. Biochem Biophys Rep. 2022. PMID: 36164562 Free PMC article.
References
-
- World Health Organization . Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. 2003.
Publication types
LinkOut - more resources
Full Text Sources